SUVEN PHARMACEUTICALS
|
The Current P/E Ratio of SUVEN PHARMACEUTICALS is 95.91.
| Share Price | ₹588.7 | Nov 21,2025 |
| Market Cap | ₹22,521.7 Cr | |
| Earnings-TTM | ₹234.8 Cr | TTM-Consolidated Results |
| Price/Earnings | 95.91x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SUVEN PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹22,521.7 Cr] as on Nov 21,2025
(/) Earnings [ ₹234.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 95.91x ]
Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay 95.91 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SUVEN PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SUVEN PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SUVEN PHARMACEUTICALS
PE Ratio Performance Analysis for SUVEN PHARMACEUTICALS
- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 53.26x.
- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 34.8x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 110.23x.
- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 29.26x.
How does SUVEN PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SUVEN PHARMACEUTICALS | 234.81 | 95.91 | 22,521.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 40.63 | 427,370.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 67.93 | 168,802.0 |
| CIPLA LTD | 5,453.86 | 22.27 | 121,481.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 58.80 | 125,841.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.87 | 102,220.0 |
| MANKIND PHARMA LTD | 1,767.06 | 51.86 | 91,632.4 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.75 | 93,237.6 |
| LUPIN LTD | 4,347.53 | 21.00 | 91,293.1 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.12 | 69,365.1 |
| ABBOTT INDIA LTD | 1,508.95 | 41.86 | 63,159.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SUVEN PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.87x |
| Max industry PE | 95.91x |
| Median industry PE | 40.63x |
| Average industry PE | 41.54x |
You may also like the below Video Courses